Rinat Neuroscience Corp.
This article was originally published in Start Up
Executive Summary
None of the marketed humanized monoclonal antibodies and very few of those in development target nervous system disorders. Rinat Neuroscience Corp. hopes to turn heads by pioneering highly targeted antibody therapies for pain, neuropathy and other neural disorders.